Furthermore, given that GLIPR1 was shown to down-regulate MYC in prostate cancer [32], the relationship between GLIPR1 expression and MYC expression in MM PCs from newly diagnosed patients was also assessed in silico. This evidence concerns the gene GLIPR1 and prostate carcinoma.